| 5.4 |
21.5 |
GO:0051796 |
regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
| 3.7 |
11.1 |
GO:1990764 |
regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 3.4 |
13.6 |
GO:0051710 |
regulation of cytolysis in other organism(GO:0051710) |
| 2.4 |
7.3 |
GO:0070563 |
negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 2.3 |
14.0 |
GO:0002760 |
positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 2.1 |
6.4 |
GO:1904301 |
positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 1.7 |
5.1 |
GO:1904784 |
NLRP1 inflammasome complex assembly(GO:1904784) |
| 1.5 |
4.5 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 1.5 |
8.9 |
GO:0045110 |
intermediate filament bundle assembly(GO:0045110) |
| 1.4 |
4.3 |
GO:0061713 |
neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
| 1.4 |
11.0 |
GO:1902613 |
regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 1.4 |
4.1 |
GO:1904761 |
negative regulation of myofibroblast differentiation(GO:1904761) |
| 1.3 |
5.3 |
GO:0001808 |
negative regulation of type IV hypersensitivity(GO:0001808) |
| 1.3 |
9.3 |
GO:0071279 |
cellular response to cobalt ion(GO:0071279) |
| 1.3 |
3.9 |
GO:0015728 |
mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
| 1.3 |
7.7 |
GO:1904222 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 1.3 |
5.0 |
GO:0086092 |
regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
| 1.2 |
12.2 |
GO:1903764 |
regulation of potassium ion export across plasma membrane(GO:1903764) |
| 1.2 |
3.6 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 1.2 |
6.1 |
GO:1905167 |
positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 1.2 |
3.6 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 1.2 |
3.6 |
GO:2000452 |
CD8-positive, alpha-beta T cell extravasation(GO:0035697) CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) positive regulation of necroptotic process(GO:0060545) regulation of T cell extravasation(GO:2000407) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
| 1.2 |
42.2 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 1.1 |
7.8 |
GO:0043163 |
cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 1.1 |
3.3 |
GO:0043449 |
cellular alkene metabolic process(GO:0043449) |
| 1.1 |
3.2 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 1.1 |
5.3 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 1.1 |
9.5 |
GO:1900623 |
regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 1.0 |
19.9 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 1.0 |
7.1 |
GO:0010046 |
response to mycotoxin(GO:0010046) |
| 1.0 |
1.0 |
GO:0007060 |
male meiosis chromosome segregation(GO:0007060) |
| 1.0 |
3.9 |
GO:0060447 |
bud outgrowth involved in lung branching(GO:0060447) |
| 1.0 |
2.9 |
GO:0008057 |
eye pigment granule organization(GO:0008057) |
| 1.0 |
3.9 |
GO:0070895 |
transposon integration(GO:0070893) regulation of transposon integration(GO:0070894) negative regulation of transposon integration(GO:0070895) |
| 1.0 |
3.9 |
GO:0072086 |
specification of loop of Henle identity(GO:0072086) |
| 0.9 |
0.9 |
GO:1904000 |
positive regulation of eating behavior(GO:1904000) |
| 0.9 |
6.5 |
GO:0060671 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.9 |
2.8 |
GO:0035674 |
tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.9 |
3.6 |
GO:1903542 |
negative regulation of exosomal secretion(GO:1903542) |
| 0.9 |
3.5 |
GO:0090095 |
regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.9 |
6.1 |
GO:0048050 |
post-embryonic eye morphogenesis(GO:0048050) |
| 0.9 |
3.4 |
GO:0006542 |
glutamine biosynthetic process(GO:0006542) |
| 0.8 |
2.5 |
GO:0048627 |
myoblast development(GO:0048627) |
| 0.8 |
5.1 |
GO:1902957 |
negative regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902957) |
| 0.8 |
9.3 |
GO:0086073 |
bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.8 |
4.2 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.8 |
4.1 |
GO:0036414 |
protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.8 |
2.4 |
GO:0032903 |
viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
| 0.8 |
2.4 |
GO:1990709 |
presynaptic active zone organization(GO:1990709) |
| 0.8 |
2.4 |
GO:1902362 |
melanocyte apoptotic process(GO:1902362) |
| 0.8 |
2.3 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.8 |
6.1 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.7 |
3.7 |
GO:0032796 |
uropod organization(GO:0032796) |
| 0.7 |
2.2 |
GO:0021503 |
neural fold bending(GO:0021503) |
| 0.7 |
2.9 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.7 |
0.7 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.7 |
2.9 |
GO:0035879 |
plasma membrane lactate transport(GO:0035879) |
| 0.7 |
2.9 |
GO:0010983 |
positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
| 0.7 |
5.7 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 0.7 |
2.8 |
GO:0061198 |
fungiform papilla formation(GO:0061198) |
| 0.7 |
3.5 |
GO:0018262 |
isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.7 |
4.1 |
GO:0097021 |
lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.7 |
5.4 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.7 |
4.7 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.7 |
1.3 |
GO:1900180 |
regulation of protein localization to nucleus(GO:1900180) |
| 0.7 |
3.3 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.7 |
2.6 |
GO:0002238 |
response to molecule of fungal origin(GO:0002238) cellular response to molecule of fungal origin(GO:0071226) |
| 0.7 |
3.3 |
GO:0010636 |
positive regulation of mitochondrial fusion(GO:0010636) |
| 0.7 |
2.6 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.7 |
2.6 |
GO:0060512 |
prostate gland morphogenesis(GO:0060512) |
| 0.6 |
1.9 |
GO:0045081 |
negative regulation of interleukin-10 biosynthetic process(GO:0045081) |
| 0.6 |
7.1 |
GO:0060753 |
regulation of mast cell chemotaxis(GO:0060753) |
| 0.6 |
0.6 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 0.6 |
2.5 |
GO:1904647 |
response to rotenone(GO:1904647) |
| 0.6 |
1.9 |
GO:1900085 |
negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 0.6 |
1.9 |
GO:0006382 |
adenosine to inosine editing(GO:0006382) |
| 0.6 |
6.3 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.6 |
1.9 |
GO:0061193 |
sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
| 0.6 |
1.2 |
GO:0036295 |
cellular response to increased oxygen levels(GO:0036295) |
| 0.6 |
0.6 |
GO:1903527 |
positive regulation of membrane tubulation(GO:1903527) |
| 0.6 |
2.5 |
GO:1903778 |
protein localization to vacuolar membrane(GO:1903778) |
| 0.6 |
3.7 |
GO:0002386 |
immune response in mucosal-associated lymphoid tissue(GO:0002386) |
| 0.6 |
2.4 |
GO:0051541 |
elastin metabolic process(GO:0051541) |
| 0.6 |
1.8 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.6 |
0.6 |
GO:1902309 |
negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.6 |
2.9 |
GO:0019732 |
antifungal humoral response(GO:0019732) |
| 0.6 |
2.9 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.6 |
0.6 |
GO:0014043 |
negative regulation of neuron maturation(GO:0014043) |
| 0.6 |
4.0 |
GO:0038172 |
interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.6 |
0.6 |
GO:2000812 |
regulation of barbed-end actin filament capping(GO:2000812) |
| 0.6 |
1.7 |
GO:1900081 |
regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
| 0.6 |
2.8 |
GO:2000638 |
regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
| 0.6 |
2.8 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.6 |
2.2 |
GO:0097252 |
oligodendrocyte apoptotic process(GO:0097252) |
| 0.6 |
0.6 |
GO:0051255 |
spindle midzone assembly(GO:0051255) |
| 0.6 |
2.8 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 0.5 |
2.7 |
GO:0071477 |
hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.5 |
2.2 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.5 |
1.1 |
GO:1902966 |
regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
| 0.5 |
2.1 |
GO:0006218 |
uridine catabolic process(GO:0006218) |
| 0.5 |
3.1 |
GO:1900245 |
positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.5 |
5.2 |
GO:1990834 |
response to odorant(GO:1990834) |
| 0.5 |
1.0 |
GO:0072535 |
tumor necrosis factor (ligand) superfamily member 11 production(GO:0072535) regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000307) |
| 0.5 |
1.6 |
GO:0038060 |
nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.5 |
2.0 |
GO:1990502 |
dense core granule maturation(GO:1990502) |
| 0.5 |
1.5 |
GO:0046832 |
negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.5 |
1.5 |
GO:0060697 |
positive regulation of phospholipid catabolic process(GO:0060697) |
| 0.5 |
2.0 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.5 |
2.5 |
GO:1904744 |
positive regulation of telomeric DNA binding(GO:1904744) |
| 0.5 |
3.5 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.5 |
2.0 |
GO:0060474 |
positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 0.5 |
1.5 |
GO:0001798 |
positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 0.5 |
1.5 |
GO:0097195 |
pilomotor reflex(GO:0097195) |
| 0.5 |
3.0 |
GO:0014718 |
positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
| 0.5 |
5.9 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 0.5 |
2.9 |
GO:0051673 |
membrane disruption in other organism(GO:0051673) |
| 0.5 |
1.5 |
GO:0034970 |
histone H3-R2 methylation(GO:0034970) |
| 0.5 |
0.5 |
GO:0018963 |
phthalate metabolic process(GO:0018963) |
| 0.5 |
2.9 |
GO:0033512 |
L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.5 |
3.3 |
GO:1903575 |
cornified envelope assembly(GO:1903575) |
| 0.5 |
1.4 |
GO:0015746 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.5 |
7.1 |
GO:0002191 |
cap-dependent translational initiation(GO:0002191) |
| 0.5 |
5.7 |
GO:0015884 |
folic acid transport(GO:0015884) |
| 0.5 |
7.1 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.5 |
1.4 |
GO:1904562 |
phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.5 |
3.7 |
GO:0007207 |
phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.5 |
5.6 |
GO:0072602 |
interleukin-4 secretion(GO:0072602) |
| 0.5 |
11.1 |
GO:0090026 |
positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.5 |
2.3 |
GO:0003366 |
cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.5 |
2.3 |
GO:0006051 |
mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 0.4 |
1.3 |
GO:0031587 |
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.4 |
2.2 |
GO:0051088 |
PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.4 |
3.1 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.4 |
1.8 |
GO:0033484 |
nitric oxide homeostasis(GO:0033484) |
| 0.4 |
4.4 |
GO:1901314 |
negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
| 0.4 |
1.3 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.4 |
2.2 |
GO:1903923 |
plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) protein processing in phagocytic vesicle(GO:1900756) regulation of plasma membrane raft polarization(GO:1903906) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
| 0.4 |
7.0 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.4 |
0.4 |
GO:0090118 |
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.4 |
7.7 |
GO:0090050 |
positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.4 |
1.3 |
GO:2001226 |
negative regulation of chloride transport(GO:2001226) |
| 0.4 |
2.5 |
GO:1902045 |
negative regulation of Fas signaling pathway(GO:1902045) |
| 0.4 |
1.3 |
GO:0061433 |
cellular response to caloric restriction(GO:0061433) negative regulation of oligodendrocyte progenitor proliferation(GO:0070446) |
| 0.4 |
4.6 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.4 |
2.9 |
GO:0035694 |
mitochondrial protein catabolic process(GO:0035694) |
| 0.4 |
0.4 |
GO:0031958 |
corticosteroid receptor signaling pathway(GO:0031958) |
| 0.4 |
1.2 |
GO:0002276 |
basophil activation involved in immune response(GO:0002276) |
| 0.4 |
0.4 |
GO:0010286 |
heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.4 |
0.8 |
GO:1903204 |
negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.4 |
2.0 |
GO:0021623 |
optic cup structural organization(GO:0003409) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
| 0.4 |
3.2 |
GO:0010836 |
negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.4 |
6.9 |
GO:0090361 |
platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.4 |
2.0 |
GO:0015917 |
aminophospholipid transport(GO:0015917) |
| 0.4 |
1.2 |
GO:0071109 |
superior temporal gyrus development(GO:0071109) |
| 0.4 |
8.9 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 0.4 |
1.6 |
GO:0018879 |
biphenyl metabolic process(GO:0018879) |
| 0.4 |
1.2 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.4 |
2.8 |
GO:0019348 |
dolichol metabolic process(GO:0019348) |
| 0.4 |
0.4 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.4 |
1.9 |
GO:0002528 |
regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.4 |
2.3 |
GO:0090283 |
regulation of protein glycosylation in Golgi(GO:0090283) |
| 0.4 |
0.8 |
GO:0048817 |
negative regulation of hair follicle maturation(GO:0048817) |
| 0.4 |
1.9 |
GO:0033029 |
neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) |
| 0.4 |
8.1 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 0.4 |
3.4 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.4 |
1.9 |
GO:0002905 |
mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
| 0.4 |
0.8 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.4 |
0.8 |
GO:0010360 |
negative regulation of anion channel activity(GO:0010360) |
| 0.4 |
3.0 |
GO:1905232 |
cellular response to L-glutamate(GO:1905232) |
| 0.4 |
2.3 |
GO:1900425 |
negative regulation of defense response to bacterium(GO:1900425) |
| 0.4 |
2.6 |
GO:1902162 |
mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.4 |
1.1 |
GO:0001579 |
medium-chain fatty acid transport(GO:0001579) |
| 0.4 |
1.5 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.4 |
2.2 |
GO:0010760 |
negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.4 |
1.1 |
GO:1904352 |
positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.4 |
1.1 |
GO:0061428 |
negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.4 |
1.8 |
GO:1904578 |
response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
| 0.4 |
2.1 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 0.4 |
1.8 |
GO:1902024 |
histidine transport(GO:0015817) L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) |
| 0.4 |
0.4 |
GO:0045763 |
negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 0.4 |
0.7 |
GO:0060382 |
regulation of DNA strand elongation(GO:0060382) |
| 0.3 |
1.0 |
GO:1901842 |
negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.3 |
0.3 |
GO:0010716 |
negative regulation of extracellular matrix disassembly(GO:0010716) |
| 0.3 |
2.8 |
GO:0042048 |
olfactory behavior(GO:0042048) |
| 0.3 |
1.7 |
GO:1904450 |
negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 0.3 |
2.4 |
GO:0072674 |
multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.3 |
3.4 |
GO:0002480 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.3 |
1.0 |
GO:1902908 |
regulation of melanosome transport(GO:1902908) |
| 0.3 |
1.0 |
GO:0048203 |
vesicle targeting, trans-Golgi to endosome(GO:0048203) |
| 0.3 |
1.4 |
GO:0035574 |
histone H4-K20 demethylation(GO:0035574) |
| 0.3 |
1.3 |
GO:0000294 |
nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.3 |
0.3 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.3 |
1.0 |
GO:0033488 |
cholesterol biosynthetic process via 24,25-dihydrolanosterol(GO:0033488) |
| 0.3 |
3.7 |
GO:0060174 |
limb bud formation(GO:0060174) |
| 0.3 |
3.6 |
GO:2000664 |
positive regulation of interleukin-5 secretion(GO:2000664) |
| 0.3 |
2.3 |
GO:0043129 |
surfactant homeostasis(GO:0043129) |
| 0.3 |
3.6 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.3 |
1.3 |
GO:0046909 |
intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.3 |
3.6 |
GO:0009134 |
nucleoside diphosphate catabolic process(GO:0009134) |
| 0.3 |
1.0 |
GO:0048875 |
chemical homeostasis within a tissue(GO:0048875) |
| 0.3 |
1.6 |
GO:1900106 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.3 |
0.7 |
GO:0072738 |
response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
| 0.3 |
0.3 |
GO:0010157 |
response to chlorate(GO:0010157) |
| 0.3 |
1.6 |
GO:0036496 |
regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 0.3 |
1.0 |
GO:0038145 |
macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.3 |
6.8 |
GO:0031268 |
pseudopodium organization(GO:0031268) |
| 0.3 |
1.9 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.3 |
1.0 |
GO:1903625 |
negative regulation of DNA catabolic process(GO:1903625) |
| 0.3 |
1.3 |
GO:0009236 |
cobalamin biosynthetic process(GO:0009236) |
| 0.3 |
1.6 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 0.3 |
1.0 |
GO:0002121 |
inter-male aggressive behavior(GO:0002121) |
| 0.3 |
1.3 |
GO:0097156 |
fasciculation of motor neuron axon(GO:0097156) |
| 0.3 |
1.9 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) |
| 0.3 |
0.3 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.3 |
6.3 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.3 |
0.6 |
GO:0086042 |
cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 0.3 |
0.9 |
GO:0042245 |
RNA repair(GO:0042245) |
| 0.3 |
1.3 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.3 |
1.2 |
GO:0010980 |
regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
| 0.3 |
0.9 |
GO:0032911 |
negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.3 |
0.3 |
GO:0015966 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.3 |
1.8 |
GO:0072658 |
maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.3 |
4.9 |
GO:0033160 |
positive regulation of protein import into nucleus, translocation(GO:0033160) |
| 0.3 |
3.0 |
GO:0046813 |
receptor-mediated virion attachment to host cell(GO:0046813) |
| 0.3 |
3.6 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.3 |
8.1 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.3 |
1.2 |
GO:0032804 |
negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
| 0.3 |
3.3 |
GO:1903672 |
positive regulation of sprouting angiogenesis(GO:1903672) |
| 0.3 |
0.9 |
GO:0046586 |
regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.3 |
0.3 |
GO:0060374 |
mast cell differentiation(GO:0060374) |
| 0.3 |
0.9 |
GO:0071630 |
nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.3 |
3.8 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.3 |
7.2 |
GO:0060004 |
reflex(GO:0060004) |
| 0.3 |
1.2 |
GO:1900138 |
negative regulation of phospholipase A2 activity(GO:1900138) |
| 0.3 |
1.2 |
GO:0010835 |
regulation of protein ADP-ribosylation(GO:0010835) |
| 0.3 |
2.3 |
GO:1902952 |
positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.3 |
3.7 |
GO:0052696 |
flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.3 |
0.8 |
GO:0007387 |
anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
| 0.3 |
4.2 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.3 |
1.1 |
GO:0035397 |
helper T cell enhancement of adaptive immune response(GO:0035397) |
| 0.3 |
0.6 |
GO:0048611 |
ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
| 0.3 |
4.7 |
GO:1902166 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
| 0.3 |
0.3 |
GO:0060022 |
hard palate development(GO:0060022) |
| 0.3 |
1.6 |
GO:0034332 |
cell-substrate adherens junction assembly(GO:0007045) adherens junction organization(GO:0034332) focal adhesion assembly(GO:0048041) |
| 0.3 |
0.8 |
GO:1902416 |
positive regulation of mRNA binding(GO:1902416) |
| 0.3 |
1.1 |
GO:0048200 |
COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.3 |
1.1 |
GO:0034721 |
histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
| 0.3 |
1.6 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.3 |
1.9 |
GO:0045541 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.3 |
0.3 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.3 |
4.0 |
GO:0016573 |
histone acetylation(GO:0016573) |
| 0.3 |
0.8 |
GO:0006117 |
acetaldehyde metabolic process(GO:0006117) |
| 0.3 |
1.3 |
GO:0035936 |
testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 0.3 |
1.6 |
GO:1900114 |
positive regulation of histone H3-K9 trimethylation(GO:1900114) |
| 0.3 |
2.1 |
GO:0051121 |
hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.3 |
0.8 |
GO:0030997 |
regulation of centriole-centriole cohesion(GO:0030997) |
| 0.3 |
1.6 |
GO:0033619 |
membrane protein ectodomain proteolysis(GO:0006509) membrane protein proteolysis(GO:0033619) |
| 0.3 |
0.5 |
GO:0002331 |
pre-B cell allelic exclusion(GO:0002331) |
| 0.3 |
3.7 |
GO:2000404 |
regulation of T cell migration(GO:2000404) |
| 0.3 |
3.7 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.3 |
0.3 |
GO:0021896 |
forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) |
| 0.3 |
13.3 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.3 |
2.6 |
GO:0019264 |
glycine biosynthetic process from serine(GO:0019264) |
| 0.3 |
1.8 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.3 |
0.3 |
GO:1903793 |
positive regulation of anion transport(GO:1903793) |
| 0.3 |
0.5 |
GO:0061535 |
glutamate secretion, neurotransmission(GO:0061535) |
| 0.3 |
1.3 |
GO:0090063 |
positive regulation of microtubule nucleation(GO:0090063) |
| 0.3 |
0.3 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
| 0.3 |
1.8 |
GO:0008218 |
bioluminescence(GO:0008218) |
| 0.3 |
5.3 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.3 |
1.3 |
GO:0002296 |
T-helper 1 cell lineage commitment(GO:0002296) |
| 0.2 |
0.5 |
GO:0001300 |
chronological cell aging(GO:0001300) |
| 0.2 |
1.7 |
GO:0051012 |
microtubule sliding(GO:0051012) |
| 0.2 |
3.7 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.2 |
1.2 |
GO:0098887 |
neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) neurotransmitter receptor transport, endosome to plasma membrane(GO:0099639) |
| 0.2 |
0.7 |
GO:0001544 |
initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.2 |
1.5 |
GO:0042335 |
cuticle development(GO:0042335) |
| 0.2 |
0.7 |
GO:0045739 |
positive regulation of DNA repair(GO:0045739) |
| 0.2 |
0.7 |
GO:0035261 |
external genitalia morphogenesis(GO:0035261) |
| 0.2 |
0.7 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.2 |
3.6 |
GO:0038007 |
netrin-activated signaling pathway(GO:0038007) |
| 0.2 |
1.2 |
GO:0030311 |
poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.2 |
1.2 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.2 |
2.6 |
GO:1901341 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.2 |
0.7 |
GO:0042097 |
interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
| 0.2 |
0.7 |
GO:1905051 |
regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.2 |
1.2 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.2 |
1.6 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
| 0.2 |
0.5 |
GO:0021592 |
fourth ventricle development(GO:0021592) |
| 0.2 |
0.7 |
GO:0032755 |
positive regulation of interleukin-6 production(GO:0032755) |
| 0.2 |
3.2 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.2 |
1.4 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.2 |
0.7 |
GO:2001247 |
positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 0.2 |
1.1 |
GO:1904885 |
beta-catenin destruction complex assembly(GO:1904885) |
| 0.2 |
0.9 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) |
| 0.2 |
0.7 |
GO:0070535 |
histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.2 |
1.4 |
GO:0010968 |
regulation of microtubule nucleation(GO:0010968) |
| 0.2 |
2.0 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.2 |
2.5 |
GO:0002084 |
protein depalmitoylation(GO:0002084) |
| 0.2 |
0.7 |
GO:0046901 |
tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 0.2 |
1.8 |
GO:2000323 |
negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.2 |
1.1 |
GO:0002329 |
pre-B cell differentiation(GO:0002329) |
| 0.2 |
1.3 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.2 |
0.9 |
GO:1905205 |
positive regulation of connective tissue replacement(GO:1905205) |
| 0.2 |
0.9 |
GO:1900041 |
negative regulation of interleukin-2 secretion(GO:1900041) |
| 0.2 |
0.9 |
GO:2000698 |
positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
| 0.2 |
0.4 |
GO:0016476 |
regulation of embryonic cell shape(GO:0016476) |
| 0.2 |
1.5 |
GO:2000490 |
negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.2 |
2.2 |
GO:0046940 |
nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.2 |
0.4 |
GO:0006726 |
eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.2 |
0.6 |
GO:0071879 |
positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
| 0.2 |
1.5 |
GO:1904381 |
Golgi apparatus mannose trimming(GO:1904381) |
| 0.2 |
0.6 |
GO:1990029 |
atrial ventricular junction remodeling(GO:0003294) atrial cardiac muscle cell to AV node cell communication by electrical coupling(GO:0086044) bundle of His cell to Purkinje myocyte communication by electrical coupling(GO:0086054) Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling(GO:0086055) regulation of Purkinje myocyte action potential(GO:0098906) vasomotion(GO:1990029) |
| 0.2 |
1.5 |
GO:0006196 |
AMP catabolic process(GO:0006196) |
| 0.2 |
0.2 |
GO:0035359 |
negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 0.2 |
1.3 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 0.2 |
0.2 |
GO:0072661 |
protein targeting to plasma membrane(GO:0072661) |
| 0.2 |
2.5 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.2 |
0.2 |
GO:0002519 |
natural killer cell tolerance induction(GO:0002519) |
| 0.2 |
0.4 |
GO:0045668 |
negative regulation of osteoblast differentiation(GO:0045668) |
| 0.2 |
1.0 |
GO:0044501 |
modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.2 |
1.6 |
GO:0097475 |
motor neuron migration(GO:0097475) |
| 0.2 |
0.8 |
GO:0043652 |
engulfment of apoptotic cell(GO:0043652) |
| 0.2 |
0.4 |
GO:0060940 |
epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
| 0.2 |
0.6 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.2 |
1.4 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.2 |
2.2 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.2 |
0.6 |
GO:0033750 |
ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
| 0.2 |
1.2 |
GO:2001295 |
malonyl-CoA biosynthetic process(GO:2001295) |
| 0.2 |
2.8 |
GO:0036484 |
trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
| 0.2 |
0.6 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.2 |
1.4 |
GO:0060982 |
coronary artery morphogenesis(GO:0060982) |
| 0.2 |
2.0 |
GO:0032461 |
positive regulation of protein oligomerization(GO:0032461) |
| 0.2 |
1.4 |
GO:2000491 |
regulation of hepatic stellate cell activation(GO:2000489) positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.2 |
0.8 |
GO:1905123 |
regulation of endosome organization(GO:1904978) regulation of glucosylceramidase activity(GO:1905123) |
| 0.2 |
0.6 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.2 |
0.8 |
GO:0008630 |
intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
| 0.2 |
1.2 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.2 |
0.8 |
GO:0006617 |
SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
| 0.2 |
0.8 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.2 |
1.0 |
GO:0045080 |
positive regulation of chemokine biosynthetic process(GO:0045080) |
| 0.2 |
2.2 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.2 |
1.4 |
GO:0097319 |
fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
| 0.2 |
2.0 |
GO:0061042 |
vascular wound healing(GO:0061042) |
| 0.2 |
0.6 |
GO:0030223 |
neutrophil differentiation(GO:0030223) |
| 0.2 |
2.0 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.2 |
0.6 |
GO:0006423 |
cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.2 |
0.6 |
GO:0016082 |
synaptic vesicle priming(GO:0016082) dense core granule exocytosis(GO:1990504) |
| 0.2 |
1.8 |
GO:0061470 |
T follicular helper cell differentiation(GO:0061470) |
| 0.2 |
1.2 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.2 |
1.0 |
GO:0001923 |
B-1 B cell differentiation(GO:0001923) |
| 0.2 |
0.4 |
GO:0045836 |
positive regulation of meiotic nuclear division(GO:0045836) |
| 0.2 |
0.2 |
GO:2000630 |
positive regulation of miRNA metabolic process(GO:2000630) |
| 0.2 |
1.7 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.2 |
0.6 |
GO:0060437 |
lung growth(GO:0060437) |
| 0.2 |
3.9 |
GO:0009313 |
oligosaccharide catabolic process(GO:0009313) |
| 0.2 |
1.4 |
GO:0034670 |
chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
| 0.2 |
1.7 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.2 |
3.1 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.2 |
1.0 |
GO:2000980 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.2 |
0.6 |
GO:0046963 |
3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
| 0.2 |
1.3 |
GO:0061767 |
negative regulation of lung blood pressure(GO:0061767) |
| 0.2 |
2.9 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 0.2 |
0.2 |
GO:0035038 |
female pronucleus assembly(GO:0035038) |
| 0.2 |
3.6 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.2 |
1.3 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.2 |
1.9 |
GO:0006552 |
leucine catabolic process(GO:0006552) |
| 0.2 |
0.4 |
GO:0045715 |
negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 0.2 |
3.4 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.2 |
0.8 |
GO:0035822 |
meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
| 0.2 |
1.9 |
GO:0045656 |
negative regulation of monocyte differentiation(GO:0045656) |
| 0.2 |
1.3 |
GO:1903788 |
mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
| 0.2 |
0.4 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.2 |
0.6 |
GO:1903525 |
regulation of membrane tubulation(GO:1903525) |
| 0.2 |
1.5 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.2 |
0.2 |
GO:1903795 |
regulation of inorganic anion transmembrane transport(GO:1903795) |
| 0.2 |
0.7 |
GO:1902963 |
regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
| 0.2 |
1.1 |
GO:0050925 |
negative regulation of negative chemotaxis(GO:0050925) |
| 0.2 |
1.5 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.2 |
1.1 |
GO:0098886 |
modification of dendritic spine(GO:0098886) |
| 0.2 |
2.4 |
GO:0046325 |
negative regulation of glucose import(GO:0046325) |
| 0.2 |
0.9 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.2 |
1.3 |
GO:1905150 |
regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.2 |
1.8 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.2 |
0.2 |
GO:0019240 |
citrulline biosynthetic process(GO:0019240) |
| 0.2 |
0.4 |
GO:1901656 |
glycoside transport(GO:1901656) |
| 0.2 |
1.3 |
GO:0032468 |
Golgi calcium ion homeostasis(GO:0032468) |
| 0.2 |
1.3 |
GO:0045824 |
negative regulation of innate immune response(GO:0045824) |
| 0.2 |
0.5 |
GO:0060370 |
susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.2 |
0.7 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.2 |
2.1 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.2 |
0.5 |
GO:0035508 |
positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
| 0.2 |
0.5 |
GO:0023019 |
signal transduction involved in regulation of gene expression(GO:0023019) |
| 0.2 |
0.2 |
GO:0046439 |
cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
| 0.2 |
1.9 |
GO:0030949 |
positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.2 |
10.2 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 0.2 |
1.4 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.2 |
1.5 |
GO:0002230 |
positive regulation of defense response to virus by host(GO:0002230) |
| 0.2 |
3.1 |
GO:1904261 |
regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.2 |
2.2 |
GO:0035092 |
sperm chromatin condensation(GO:0035092) |
| 0.2 |
3.7 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.2 |
1.0 |
GO:0035965 |
cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.2 |
2.2 |
GO:0042532 |
negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
| 0.2 |
0.2 |
GO:2001027 |
negative regulation of endothelial cell chemotaxis(GO:2001027) |
| 0.2 |
0.7 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.2 |
5.2 |
GO:0050821 |
protein stabilization(GO:0050821) |
| 0.2 |
1.3 |
GO:0036166 |
phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 0.2 |
1.0 |
GO:0030037 |
actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.2 |
0.5 |
GO:0098976 |
excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.2 |
0.3 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.2 |
1.2 |
GO:0032185 |
septin cytoskeleton organization(GO:0032185) |
| 0.2 |
0.7 |
GO:0090487 |
toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
| 0.2 |
0.5 |
GO:0050773 |
regulation of dendrite development(GO:0050773) |
| 0.2 |
0.7 |
GO:0036015 |
response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.2 |
0.8 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.2 |
3.6 |
GO:0007191 |
adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.2 |
0.3 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.2 |
0.3 |
GO:0002439 |
chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 0.2 |
0.8 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.2 |
1.0 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.2 |
2.9 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.2 |
0.2 |
GO:1903423 |
positive regulation of synaptic vesicle endocytosis(GO:1900244) positive regulation of synaptic vesicle recycling(GO:1903423) |
| 0.2 |
1.3 |
GO:0051901 |
positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.2 |
1.3 |
GO:0071802 |
negative regulation of podosome assembly(GO:0071802) |
| 0.2 |
0.5 |
GO:0060406 |
positive regulation of penile erection(GO:0060406) |
| 0.2 |
1.9 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.2 |
0.2 |
GO:0043400 |
cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
| 0.2 |
0.2 |
GO:0043084 |
penile erection(GO:0043084) |
| 0.2 |
0.2 |
GO:0065002 |
intracellular protein transmembrane transport(GO:0065002) |
| 0.2 |
4.5 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.2 |
0.9 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.2 |
1.7 |
GO:0090141 |
positive regulation of mitochondrial fission(GO:0090141) |
| 0.2 |
0.3 |
GO:0031291 |
Ran protein signal transduction(GO:0031291) |
| 0.2 |
10.1 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.2 |
1.1 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.2 |
1.4 |
GO:0048298 |
positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.2 |
0.6 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
| 0.2 |
1.5 |
GO:1901098 |
positive regulation of autophagosome maturation(GO:1901098) |
| 0.2 |
0.2 |
GO:0001541 |
ovarian follicle development(GO:0001541) |
| 0.2 |
0.2 |
GO:0018894 |
dibenzo-p-dioxin metabolic process(GO:0018894) |
| 0.2 |
0.9 |
GO:0061084 |
regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.2 |
0.3 |
GO:0002188 |
translation reinitiation(GO:0002188) |
| 0.2 |
0.2 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.2 |
0.5 |
GO:0007549 |
dosage compensation(GO:0007549) |
| 0.2 |
0.6 |
GO:0060266 |
negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
| 0.2 |
2.4 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.2 |
2.3 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
| 0.1 |
2.7 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
| 0.1 |
0.3 |
GO:0001992 |
regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.1 |
0.6 |
GO:1904116 |
response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.1 |
0.6 |
GO:0006210 |
pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 0.1 |
0.9 |
GO:0033630 |
positive regulation of cell adhesion mediated by integrin(GO:0033630) |
| 0.1 |
1.3 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) |
| 0.1 |
0.4 |
GO:1903233 |
regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) calcium ion transport from cytosol to endoplasmic reticulum(GO:1903515) |
| 0.1 |
0.3 |
GO:0042636 |
negative regulation of hair cycle(GO:0042636) |
| 0.1 |
2.6 |
GO:0007614 |
short-term memory(GO:0007614) |
| 0.1 |
3.2 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.1 |
0.6 |
GO:0048073 |
regulation of eye pigmentation(GO:0048073) |
| 0.1 |
1.6 |
GO:0060252 |
positive regulation of glial cell proliferation(GO:0060252) |
| 0.1 |
0.7 |
GO:0031947 |
negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) negative regulation of steroid hormone biosynthetic process(GO:0090032) |
| 0.1 |
0.1 |
GO:1903895 |
negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.1 |
0.1 |
GO:1903306 |
negative regulation of regulated secretory pathway(GO:1903306) |
| 0.1 |
0.1 |
GO:1990785 |
response to water-immersion restraint stress(GO:1990785) |
| 0.1 |
2.6 |
GO:0015816 |
glycine transport(GO:0015816) |
| 0.1 |
0.6 |
GO:1901727 |
positive regulation of histone deacetylase activity(GO:1901727) |
| 0.1 |
0.9 |
GO:0061053 |
somite development(GO:0061053) |
| 0.1 |
0.4 |
GO:1990108 |
protein linear deubiquitination(GO:1990108) |
| 0.1 |
0.1 |
GO:0002361 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.1 |
0.3 |
GO:0045994 |
positive regulation of translational initiation by iron(GO:0045994) |
| 0.1 |
1.1 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 0.1 |
0.8 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.1 |
1.3 |
GO:0006749 |
glutathione metabolic process(GO:0006749) |
| 0.1 |
0.4 |
GO:0090009 |
primitive streak formation(GO:0090009) |
| 0.1 |
0.6 |
GO:0001835 |
blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.1 |
3.2 |
GO:0010934 |
macrophage cytokine production(GO:0010934) |
| 0.1 |
0.6 |
GO:0048842 |
positive regulation of axon extension involved in axon guidance(GO:0048842) |
| 0.1 |
0.4 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.1 |
0.6 |
GO:0015808 |
L-alanine transport(GO:0015808) |
| 0.1 |
0.1 |
GO:1990168 |
protein K33-linked deubiquitination(GO:1990168) |
| 0.1 |
1.0 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.1 |
2.2 |
GO:0046520 |
sphingoid biosynthetic process(GO:0046520) |
| 0.1 |
0.3 |
GO:0010751 |
negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.1 |
0.3 |
GO:0032289 |
central nervous system myelin formation(GO:0032289) |
| 0.1 |
0.4 |
GO:0061356 |
Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
| 0.1 |
1.1 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.1 |
1.6 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.1 |
0.4 |
GO:0019364 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.1 |
0.3 |
GO:2000374 |
regulation of oxygen metabolic process(GO:2000374) |
| 0.1 |
0.7 |
GO:0070458 |
cellular detoxification of nitrogen compound(GO:0070458) |
| 0.1 |
0.5 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
| 0.1 |
0.3 |
GO:0000711 |
meiotic DNA repair synthesis(GO:0000711) |
| 0.1 |
0.3 |
GO:0010877 |
lipid transport involved in lipid storage(GO:0010877) |
| 0.1 |
0.3 |
GO:0038001 |
paracrine signaling(GO:0038001) |
| 0.1 |
1.5 |
GO:0009414 |
response to water deprivation(GO:0009414) |
| 0.1 |
3.0 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.1 |
0.3 |
GO:0090611 |
ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.1 |
1.1 |
GO:0070970 |
interleukin-2 secretion(GO:0070970) |
| 0.1 |
0.1 |
GO:0071877 |
regulation of adrenergic receptor signaling pathway(GO:0071877) |
| 0.1 |
0.1 |
GO:0015870 |
acetylcholine transport(GO:0015870) |
| 0.1 |
0.5 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.1 |
0.5 |
GO:0048698 |
negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.1 |
0.3 |
GO:0048003 |
antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.1 |
0.3 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.1 |
0.6 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.1 |
1.2 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 |
0.9 |
GO:0060242 |
contact inhibition(GO:0060242) |
| 0.1 |
0.4 |
GO:0003408 |
optic cup formation involved in camera-type eye development(GO:0003408) |
| 0.1 |
0.5 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 0.1 |
0.5 |
GO:0008380 |
RNA splicing(GO:0008380) |
| 0.1 |
0.5 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.1 |
0.5 |
GO:0045137 |
gonad development(GO:0008406) development of primary sexual characteristics(GO:0045137) |
| 0.1 |
0.4 |
GO:0042471 |
ear morphogenesis(GO:0042471) |
| 0.1 |
3.1 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.1 |
7.0 |
GO:1901998 |
toxin transport(GO:1901998) |
| 0.1 |
0.5 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.1 |
0.6 |
GO:0009597 |
detection of virus(GO:0009597) |
| 0.1 |
1.1 |
GO:0035494 |
SNARE complex disassembly(GO:0035494) |
| 0.1 |
0.4 |
GO:0048250 |
mitochondrial iron ion transport(GO:0048250) |
| 0.1 |
2.6 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.1 |
0.4 |
GO:0061485 |
memory T cell proliferation(GO:0061485) |
| 0.1 |
0.2 |
GO:0051794 |
catagen(GO:0042637) regulation of catagen(GO:0051794) |
| 0.1 |
0.7 |
GO:2001300 |
lipoxin metabolic process(GO:2001300) |
| 0.1 |
0.4 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 0.1 |
1.7 |
GO:0035455 |
response to interferon-alpha(GO:0035455) |
| 0.1 |
0.2 |
GO:0042495 |
toll-like receptor 1 signaling pathway(GO:0034130) detection of triacyl bacterial lipopeptide(GO:0042495) detection of bacterial lipopeptide(GO:0070340) |
| 0.1 |
0.6 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.1 |
0.6 |
GO:1902959 |
regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) regulation of aspartic-type peptidase activity(GO:1905245) |
| 0.1 |
3.0 |
GO:0061157 |
mRNA destabilization(GO:0061157) |
| 0.1 |
0.6 |
GO:0021564 |
vagus nerve development(GO:0021564) |
| 0.1 |
0.6 |
GO:1904693 |
midbrain morphogenesis(GO:1904693) |
| 0.1 |
2.1 |
GO:0060219 |
camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.1 |
7.6 |
GO:0042771 |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.1 |
0.5 |
GO:0060729 |
intestinal epithelial structure maintenance(GO:0060729) |
| 0.1 |
0.7 |
GO:0033184 |
positive regulation of histone ubiquitination(GO:0033184) regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.1 |
1.3 |
GO:0033089 |
positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.1 |
2.3 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.1 |
0.5 |
GO:0060178 |
regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
| 0.1 |
1.3 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.1 |
1.3 |
GO:0019720 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.1 |
0.4 |
GO:0036493 |
positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
| 0.1 |
0.6 |
GO:0071475 |
cellular hyperosmotic salinity response(GO:0071475) |
| 0.1 |
3.4 |
GO:0043616 |
keratinocyte proliferation(GO:0043616) |
| 0.1 |
0.4 |
GO:0006579 |
amino-acid betaine catabolic process(GO:0006579) |
| 0.1 |
0.7 |
GO:0055118 |
negative regulation of cardiac muscle contraction(GO:0055118) |
| 0.1 |
0.2 |
GO:0034165 |
positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
| 0.1 |
0.2 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.1 |
0.4 |
GO:1904017 |
cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.1 |
1.1 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.1 |
0.5 |
GO:2000434 |
regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 0.1 |
0.1 |
GO:0050720 |
interleukin-1 biosynthetic process(GO:0042222) interleukin-1 beta biosynthetic process(GO:0050720) |
| 0.1 |
12.9 |
GO:0070268 |
cornification(GO:0070268) |
| 0.1 |
0.9 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.1 |
0.7 |
GO:1903599 |
positive regulation of mitophagy(GO:1903599) |
| 0.1 |
1.4 |
GO:1903959 |
regulation of anion transmembrane transport(GO:1903959) |
| 0.1 |
1.0 |
GO:0035583 |
sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.1 |
0.3 |
GO:0038178 |
complement component C5a signaling pathway(GO:0038178) |
| 0.1 |
2.1 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.1 |
0.7 |
GO:0019542 |
acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
| 0.1 |
0.2 |
GO:0060339 |
negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.1 |
0.3 |
GO:0034976 |
response to endoplasmic reticulum stress(GO:0034976) |
| 0.1 |
0.7 |
GO:0044805 |
late nucleophagy(GO:0044805) |
| 0.1 |
0.8 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.1 |
3.2 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.1 |
0.3 |
GO:0030187 |
melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
| 0.1 |
0.9 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.1 |
0.7 |
GO:2000537 |
regulation of cGMP-mediated signaling(GO:0010752) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
| 0.1 |
4.1 |
GO:1903393 |
positive regulation of adherens junction organization(GO:1903393) |
| 0.1 |
2.9 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.1 |
0.5 |
GO:0006068 |
ethanol catabolic process(GO:0006068) |
| 0.1 |
0.3 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.1 |
0.7 |
GO:0071971 |
extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
| 0.1 |
0.1 |
GO:0072076 |
nephrogenic mesenchyme development(GO:0072076) |
| 0.1 |
0.2 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.1 |
0.3 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.1 |
0.9 |
GO:0098706 |
ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.1 |
1.9 |
GO:0001829 |
trophectodermal cell differentiation(GO:0001829) |
| 0.1 |
2.5 |
GO:0009083 |
branched-chain amino acid catabolic process(GO:0009083) |
| 0.1 |
0.1 |
GO:0042116 |
macrophage activation(GO:0042116) |
| 0.1 |
0.3 |
GO:1900108 |
negative regulation of nodal signaling pathway(GO:1900108) |
| 0.1 |
2.0 |
GO:0006405 |
RNA export from nucleus(GO:0006405) |
| 0.1 |
0.4 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.1 |
0.4 |
GO:0097498 |
endothelial tube lumen extension(GO:0097498) |
| 0.1 |
0.6 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.1 |
1.3 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 |
1.5 |
GO:0003360 |
brainstem development(GO:0003360) |
| 0.1 |
0.9 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.1 |
1.8 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
| 0.1 |
0.5 |
GO:1900227 |
positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.1 |
1.0 |
GO:0048820 |
hair follicle maturation(GO:0048820) |
| 0.1 |
1.7 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.1 |
1.4 |
GO:0098814 |
spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 0.1 |
0.4 |
GO:1902766 |
skeletal muscle satellite cell migration(GO:1902766) |
| 0.1 |
0.7 |
GO:0060283 |
negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
| 0.1 |
4.8 |
GO:0045773 |
positive regulation of axon extension(GO:0045773) |
| 0.1 |
0.7 |
GO:2001288 |
positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.1 |
0.9 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.1 |
1.6 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.1 |
0.2 |
GO:0009608 |
response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
| 0.1 |
0.5 |
GO:1902951 |
negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.1 |
0.3 |
GO:0006433 |
prolyl-tRNA aminoacylation(GO:0006433) |
| 0.1 |
2.0 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.1 |
0.8 |
GO:2000825 |
positive regulation of androgen receptor activity(GO:2000825) |
| 0.1 |
0.7 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
| 0.1 |
0.2 |
GO:0048864 |
stem cell development(GO:0048864) |
| 0.1 |
0.3 |
GO:1903215 |
negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.1 |
0.6 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.1 |
0.8 |
GO:0046133 |
pyrimidine ribonucleoside catabolic process(GO:0046133) |
| 0.1 |
0.3 |
GO:0044800 |
fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.1 |
0.3 |
GO:0038193 |
thromboxane A2 signaling pathway(GO:0038193) |
| 0.1 |
0.3 |
GO:0098728 |
germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.1 |
0.1 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
| 0.1 |
0.7 |
GO:0098914 |
membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.1 |
0.4 |
GO:0046338 |
phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.1 |
1.1 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.1 |
0.7 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.1 |
1.2 |
GO:0001954 |
positive regulation of cell-matrix adhesion(GO:0001954) |
| 0.1 |
0.1 |
GO:0048839 |
inner ear development(GO:0048839) |
| 0.1 |
0.5 |
GO:0045657 |
positive regulation of monocyte differentiation(GO:0045657) |
| 0.1 |
0.1 |
GO:0002739 |
regulation of cytokine secretion involved in immune response(GO:0002739) |
| 0.1 |
0.3 |
GO:0060254 |
regulation of N-terminal protein palmitoylation(GO:0060254) negative regulation of N-terminal protein palmitoylation(GO:0060262) negative regulation of protein lipidation(GO:1903060) |
| 0.1 |
0.4 |
GO:0072138 |
mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
| 0.1 |
1.9 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 0.1 |
0.9 |
GO:0045329 |
carnitine biosynthetic process(GO:0045329) |
| 0.1 |
0.7 |
GO:0060215 |
primitive hemopoiesis(GO:0060215) |
| 0.1 |
0.5 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
| 0.1 |
0.1 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 0.1 |
0.3 |
GO:2000504 |
positive regulation of blood vessel remodeling(GO:2000504) |
| 0.1 |
1.3 |
GO:0006704 |
glucocorticoid biosynthetic process(GO:0006704) |
| 0.1 |
0.2 |
GO:0006801 |
superoxide metabolic process(GO:0006801) |
| 0.1 |
0.3 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.1 |
0.1 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.1 |
0.5 |
GO:0036018 |
cellular response to erythropoietin(GO:0036018) |
| 0.1 |
0.8 |
GO:0045950 |
negative regulation of mitotic recombination(GO:0045950) |
| 0.1 |
2.0 |
GO:0060441 |
epithelial tube branching involved in lung morphogenesis(GO:0060441) |
| 0.1 |
1.8 |
GO:0030511 |
positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.1 |
0.3 |
GO:0010615 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 0.1 |
1.3 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.1 |
0.2 |
GO:0010266 |
response to vitamin B1(GO:0010266) |
| 0.1 |
1.9 |
GO:0097435 |
fibril organization(GO:0097435) |
| 0.1 |
0.5 |
GO:0030573 |
bile acid catabolic process(GO:0030573) |
| 0.1 |
0.3 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 |
2.0 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 |
0.5 |
GO:0042159 |
lipoprotein catabolic process(GO:0042159) |
| 0.1 |
1.3 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.1 |
0.9 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.1 |
0.6 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.1 |
5.0 |
GO:0002381 |
immunoglobulin production involved in immunoglobulin mediated immune response(GO:0002381) |
| 0.1 |
0.2 |
GO:0001927 |
exocyst assembly(GO:0001927) |
| 0.1 |
0.2 |
GO:0033685 |
negative regulation of luteinizing hormone secretion(GO:0033685) |
| 0.1 |
0.5 |
GO:1903593 |
regulation of histamine secretion by mast cell(GO:1903593) |
| 0.1 |
2.1 |
GO:0007176 |
regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.1 |
0.2 |
GO:0070350 |
white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
| 0.1 |
0.5 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.1 |
0.4 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.1 |
0.5 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.1 |
0.1 |
GO:0003357 |
noradrenergic neuron differentiation(GO:0003357) |
| 0.1 |
0.7 |
GO:0060701 |
negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
| 0.1 |
1.2 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.1 |
2.3 |
GO:0046596 |
regulation of viral entry into host cell(GO:0046596) |
| 0.1 |
1.0 |
GO:1904646 |
cellular response to beta-amyloid(GO:1904646) |
| 0.1 |
1.1 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.1 |
1.3 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.1 |
0.7 |
GO:0015860 |
purine nucleoside transmembrane transport(GO:0015860) |
| 0.1 |
0.3 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 0.1 |
0.3 |
GO:2000588 |
positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
| 0.1 |
1.4 |
GO:0035404 |
histone-serine phosphorylation(GO:0035404) |
| 0.1 |
1.5 |
GO:0033561 |
regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
| 0.1 |
0.5 |
GO:0042986 |
positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.1 |
0.3 |
GO:0046022 |
positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.1 |
1.0 |
GO:0070813 |
hydrogen sulfide metabolic process(GO:0070813) |
| 0.1 |
0.3 |
GO:0070384 |
Harderian gland development(GO:0070384) |
| 0.1 |
0.4 |
GO:0043932 |
ossification involved in bone remodeling(GO:0043932) |
| 0.1 |
0.2 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.1 |
1.4 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.1 |
0.2 |
GO:1901739 |
positive regulation of syncytium formation by plasma membrane fusion(GO:0060143) regulation of myoblast fusion(GO:1901739) |
| 0.1 |
3.5 |
GO:0050891 |
multicellular organismal water homeostasis(GO:0050891) |
| 0.1 |
0.3 |
GO:0061196 |
fungiform papilla development(GO:0061196) fungiform papilla morphogenesis(GO:0061197) |
| 0.1 |
0.3 |
GO:0070781 |
response to biotin(GO:0070781) |
| 0.1 |
0.3 |
GO:0035425 |
autocrine signaling(GO:0035425) |
| 0.1 |
0.4 |
GO:1902774 |
late endosome to lysosome transport(GO:1902774) |
| 0.1 |
2.8 |
GO:0098927 |
vesicle-mediated transport between endosomal compartments(GO:0098927) |
| 0.1 |
0.3 |
GO:0010248 |
establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.1 |
0.3 |
GO:0031935 |
regulation of chromatin silencing(GO:0031935) |
| 0.1 |
1.5 |
GO:0061099 |
negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.1 |
3.0 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.1 |
1.7 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.1 |
0.5 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 |
0.8 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.1 |
2.2 |
GO:0098743 |
cell aggregation(GO:0098743) |
| 0.1 |
0.5 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.1 |
0.2 |
GO:0051492 |
regulation of stress fiber assembly(GO:0051492) |
| 0.1 |
0.2 |
GO:1905098 |
negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.1 |
0.7 |
GO:1903800 |
positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.1 |
0.7 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.1 |
0.3 |
GO:0033080 |
immature T cell proliferation in thymus(GO:0033080) regulation of immature T cell proliferation in thymus(GO:0033084) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.1 |
0.2 |
GO:0002475 |
antigen processing and presentation via MHC class Ib(GO:0002475) |
| 0.1 |
0.5 |
GO:1901355 |
cellular response to rapamycin(GO:0072752) response to rapamycin(GO:1901355) |
| 0.1 |
1.6 |
GO:0035458 |
cellular response to interferon-beta(GO:0035458) |
| 0.1 |
1.8 |
GO:0045063 |
T-helper 1 cell differentiation(GO:0045063) |
| 0.1 |
1.3 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.1 |
0.2 |
GO:0035513 |
oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
| 0.1 |
0.8 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.1 |
0.2 |
GO:0090045 |
positive regulation of deacetylase activity(GO:0090045) |
| 0.1 |
0.2 |
GO:0032497 |
detection of lipopolysaccharide(GO:0032497) |
| 0.1 |
1.4 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 |
0.4 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.1 |
0.9 |
GO:0036010 |
protein localization to endosome(GO:0036010) |
| 0.1 |
1.4 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.1 |
0.3 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.1 |
0.7 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.1 |
0.5 |
GO:0002902 |
regulation of B cell apoptotic process(GO:0002902) |
| 0.1 |
1.5 |
GO:0060213 |
regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.1 |
0.2 |
GO:0046463 |
neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
| 0.1 |
1.4 |
GO:0035767 |
endothelial cell chemotaxis(GO:0035767) |
| 0.1 |
0.6 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 |
1.0 |
GO:0035826 |
rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.1 |
0.2 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.1 |
0.2 |
GO:0023035 |
CD40 signaling pathway(GO:0023035) |
| 0.1 |
0.8 |
GO:0030277 |
maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.1 |
2.4 |
GO:0014046 |
dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.1 |
0.7 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.1 |
0.3 |
GO:0042351 |
'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
| 0.1 |
0.5 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 |
7.4 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.1 |
0.1 |
GO:1990426 |
homologous recombination-dependent replication fork processing(GO:1990426) |
| 0.1 |
0.5 |
GO:0090234 |
regulation of kinetochore assembly(GO:0090234) |
| 0.1 |
0.3 |
GO:0045040 |
protein import into mitochondrial outer membrane(GO:0045040) |
| 0.1 |
1.0 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.1 |
0.1 |
GO:0060157 |
urinary bladder development(GO:0060157) |
| 0.1 |
0.1 |
GO:0007039 |
protein catabolic process in the vacuole(GO:0007039) |
| 0.1 |
0.9 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.1 |
0.4 |
GO:0001957 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.1 |
0.3 |
GO:0045670 |
regulation of osteoclast differentiation(GO:0045670) |
| 0.1 |
0.1 |
GO:2001015 |
negative regulation of skeletal muscle cell differentiation(GO:2001015) |
| 0.1 |
0.4 |
GO:0045453 |
bone resorption(GO:0045453) |
| 0.1 |
1.1 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.1 |
0.6 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
| 0.1 |
0.4 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.1 |
0.4 |
GO:1900169 |
regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 0.1 |
0.9 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.1 |
0.2 |
GO:0071493 |
cellular response to UV-B(GO:0071493) |
| 0.1 |
4.4 |
GO:0046580 |
negative regulation of Ras protein signal transduction(GO:0046580) |
| 0.1 |
1.1 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.1 |
0.6 |
GO:0048712 |
negative regulation of astrocyte differentiation(GO:0048712) |
| 0.1 |
0.4 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.1 |
0.7 |
GO:1902570 |
protein localization to nucleolus(GO:1902570) |
| 0.1 |
0.3 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 0.1 |
0.3 |
GO:0046502 |
uroporphyrinogen III biosynthetic process(GO:0006780) succinyl-CoA pathway(GO:0006781) uroporphyrinogen III metabolic process(GO:0046502) |
| 0.1 |
0.1 |
GO:0072361 |
regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
| 0.1 |
0.1 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.1 |
0.3 |
GO:0043335 |
protein unfolding(GO:0043335) |
| 0.1 |
0.3 |
GO:1903385 |
regulation of homophilic cell adhesion(GO:1903385) |
| 0.1 |
0.1 |
GO:1903214 |
regulation of protein targeting to mitochondrion(GO:1903214) |
| 0.1 |
0.7 |
GO:0060605 |
tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.1 |
0.6 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.1 |
0.1 |
GO:0010918 |
positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.1 |
0.3 |
GO:1903070 |
negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.1 |
0.5 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.1 |
0.1 |
GO:0010002 |
cardioblast differentiation(GO:0010002) |
| 0.1 |
4.4 |
GO:0031529 |
ruffle organization(GO:0031529) |
| 0.1 |
0.4 |
GO:0090625 |
mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
| 0.1 |
0.5 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.1 |
0.7 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.1 |
0.4 |
GO:0016447 |
somatic recombination of immunoglobulin gene segments(GO:0016447) |
| 0.1 |
4.2 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.1 |
0.1 |
GO:1990535 |
neuron projection maintenance(GO:1990535) |
| 0.1 |
0.6 |
GO:0051923 |
sulfation(GO:0051923) |
| 0.1 |
1.6 |
GO:0042130 |
negative regulation of T cell proliferation(GO:0042130) |
| 0.1 |
0.3 |
GO:0071478 |
cellular response to radiation(GO:0071478) |
| 0.1 |
1.7 |
GO:0015936 |
coenzyme A metabolic process(GO:0015936) |
| 0.1 |
0.2 |
GO:0051801 |
cytolysis by symbiont of host cells(GO:0001897) cytolysis in other organism involved in symbiotic interaction(GO:0051801) |
| 0.1 |
2.5 |
GO:0001913 |
T cell mediated cytotoxicity(GO:0001913) |
| 0.1 |
0.4 |
GO:0050917 |
sensory perception of umami taste(GO:0050917) |
| 0.1 |
8.5 |
GO:0090630 |
activation of GTPase activity(GO:0090630) |
| 0.1 |
0.3 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
| 0.1 |
1.1 |
GO:0048706 |
embryonic skeletal system development(GO:0048706) |
| 0.1 |
0.8 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 |
0.2 |
GO:0018008 |
N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 0.1 |
0.8 |
GO:2000291 |
regulation of myoblast proliferation(GO:2000291) |
| 0.1 |
0.1 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.1 |
0.2 |
GO:1902093 |
positive regulation of sperm motility(GO:1902093) |
| 0.1 |
0.3 |
GO:0034378 |
chylomicron assembly(GO:0034378) |
| 0.1 |
0.5 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.1 |
0.7 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.1 |
0.4 |
GO:0002888 |
positive regulation of myeloid leukocyte mediated immunity(GO:0002888) |
| 0.1 |
0.1 |
GO:1900226 |
negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.1 |
1.1 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.1 |
0.9 |
GO:0097237 |
cellular response to toxic substance(GO:0097237) |
| 0.1 |
0.2 |
GO:0090107 |
regulation of high-density lipoprotein particle assembly(GO:0090107) |
| 0.1 |
0.6 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 0.1 |
8.5 |
GO:1902476 |
chloride transmembrane transport(GO:1902476) |
| 0.1 |
0.4 |
GO:0035610 |
protein side chain deglutamylation(GO:0035610) |
| 0.1 |
0.1 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.1 |
0.5 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.1 |
0.9 |
GO:0097581 |
lamellipodium organization(GO:0097581) |
| 0.1 |
0.4 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.1 |
0.5 |
GO:0010614 |
negative regulation of cardiac muscle hypertrophy(GO:0010614) |
| 0.1 |
0.6 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.1 |
0.1 |
GO:2000973 |
positive regulation of B cell apoptotic process(GO:0002904) regulation of pro-B cell differentiation(GO:2000973) |
| 0.1 |
0.1 |
GO:0002016 |
regulation of blood volume by renin-angiotensin(GO:0002016) |
| 0.1 |
0.8 |
GO:0033169 |
histone H3-K9 demethylation(GO:0033169) |
| 0.1 |
0.2 |
GO:0007603 |
phototransduction, visible light(GO:0007603) |
| 0.1 |
0.4 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 |
0.4 |
GO:0060491 |
regulation of cell projection assembly(GO:0060491) |
| 0.1 |
0.4 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.1 |
0.2 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.1 |
1.0 |
GO:2000052 |
positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.1 |
0.2 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.1 |
0.6 |
GO:2000010 |
positive regulation of protein localization to cell surface(GO:2000010) |
| 0.1 |
0.1 |
GO:1990036 |
regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) calcium ion import into sarcoplasmic reticulum(GO:1990036) |
| 0.1 |
0.4 |
GO:0097396 |
response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.1 |
0.3 |
GO:0097211 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.1 |
0.8 |
GO:0030220 |
platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
| 0.1 |
0.2 |
GO:0035234 |
ectopic germ cell programmed cell death(GO:0035234) |
| 0.1 |
0.2 |
GO:0060168 |
regulation of adenosine receptor signaling pathway(GO:0060167) positive regulation of adenosine receptor signaling pathway(GO:0060168) |
| 0.1 |
0.4 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.1 |
0.4 |
GO:0098856 |
intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
| 0.1 |
0.2 |
GO:0033341 |
regulation of collagen binding(GO:0033341) |
| 0.1 |
0.1 |
GO:1901628 |
positive regulation of postsynaptic membrane organization(GO:1901628) positive regulation of receptor clustering(GO:1903911) |
| 0.1 |
0.2 |
GO:0048511 |
rhythmic process(GO:0048511) |
| 0.1 |
0.2 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.1 |
0.5 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.1 |
0.1 |
GO:0099638 |
endosome to plasma membrane protein transport(GO:0099638) |
| 0.1 |
0.2 |
GO:0051037 |
regulation of transcription involved in meiotic cell cycle(GO:0051037) |
| 0.1 |
0.4 |
GO:1990481 |
mRNA pseudouridine synthesis(GO:1990481) |
| 0.1 |
0.4 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.1 |
0.2 |
GO:2000767 |
positive regulation of cytoplasmic translation(GO:2000767) |
| 0.1 |
0.6 |
GO:0098877 |
neurotransmitter receptor transport to plasma membrane(GO:0098877) neurotransmitter receptor transport to postsynaptic membrane(GO:0098969) establishment of protein localization to postsynaptic membrane(GO:1903540) |
| 0.1 |
0.7 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.1 |
0.1 |
GO:0030916 |
otic vesicle formation(GO:0030916) |
| 0.1 |
0.8 |
GO:0006228 |
UTP biosynthetic process(GO:0006228) |
| 0.1 |
1.1 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.1 |
0.4 |
GO:0050910 |
detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.1 |
0.2 |
GO:0009068 |
aspartate family amino acid catabolic process(GO:0009068) |
| 0.1 |
0.2 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.1 |
0.3 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
| 0.1 |
1.1 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.1 |
0.1 |
GO:0001909 |
leukocyte mediated cytotoxicity(GO:0001909) |
| 0.1 |
3.4 |
GO:0006413 |
translational initiation(GO:0006413) |
| 0.1 |
1.3 |
GO:0045066 |
regulatory T cell differentiation(GO:0045066) regulation of regulatory T cell differentiation(GO:0045589) |
| 0.1 |
0.3 |
GO:0046626 |
regulation of insulin receptor signaling pathway(GO:0046626) |
| 0.1 |
1.0 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.1 |
0.3 |
GO:0006127 |
glycerophosphate shuttle(GO:0006127) |
| 0.1 |
0.2 |
GO:0007096 |
regulation of exit from mitosis(GO:0007096) |
| 0.1 |
0.4 |
GO:0042770 |
signal transduction in response to DNA damage(GO:0042770) |
| 0.1 |
4.3 |
GO:1900181 |
negative regulation of protein localization to nucleus(GO:1900181) |
| 0.1 |
0.6 |
GO:0044597 |
polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.1 |
0.7 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 |
0.1 |
GO:0003431 |
growth plate cartilage chondrocyte development(GO:0003431) |
| 0.1 |
0.3 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.1 |
0.1 |
GO:0055089 |
fatty acid homeostasis(GO:0055089) |
| 0.1 |
1.9 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.1 |
1.7 |
GO:0022400 |
regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.1 |
0.2 |
GO:0042982 |
amyloid precursor protein metabolic process(GO:0042982) |
| 0.1 |
0.2 |
GO:0051176 |
positive regulation of sulfur metabolic process(GO:0051176) |
| 0.1 |
0.6 |
GO:0051932 |
synaptic transmission, GABAergic(GO:0051932) |
| 0.1 |
0.3 |
GO:0014029 |
neural crest formation(GO:0014029) |
| 0.1 |
0.5 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
| 0.1 |
0.7 |
GO:0021692 |
cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
| 0.1 |
0.1 |
GO:0023021 |
termination of signal transduction(GO:0023021) |
| 0.1 |
0.6 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.1 |
0.2 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.1 |
0.9 |
GO:0032212 |
positive regulation of telomere maintenance via telomerase(GO:0032212) |
| 0.1 |
1.4 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 0.1 |
0.6 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.0 |
1.0 |
GO:0032802 |
low-density lipoprotein particle receptor catabolic process(GO:0032802) |
| 0.0 |
0.2 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.0 |
0.1 |
GO:0048840 |
otolith development(GO:0048840) |
| 0.0 |
0.0 |
GO:0051904 |
pigment granule transport(GO:0051904) |
| 0.0 |
0.3 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.0 |
0.1 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.0 |
1.3 |
GO:0030199 |
collagen fibril organization(GO:0030199) |
| 0.0 |
1.2 |
GO:0007616 |
long-term memory(GO:0007616) |
| 0.0 |
0.1 |
GO:1904798 |
positive regulation of core promoter binding(GO:1904798) |
| 0.0 |
0.1 |
GO:0032964 |
collagen biosynthetic process(GO:0032964) |
| 0.0 |
2.9 |
GO:0042035 |
regulation of cytokine biosynthetic process(GO:0042035) |
| 0.0 |
0.1 |
GO:0070229 |
negative regulation of lymphocyte apoptotic process(GO:0070229) |
| 0.0 |
0.1 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 0.0 |
0.2 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.0 |
0.1 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.0 |
0.2 |
GO:0060686 |
negative regulation of prostatic bud formation(GO:0060686) |
| 0.0 |
0.1 |
GO:0032494 |
response to peptidoglycan(GO:0032494) |
| 0.0 |
0.3 |
GO:0043435 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.0 |
0.3 |
GO:0090070 |
positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.0 |
0.1 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 0.0 |
0.3 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.0 |
0.1 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.0 |
0.5 |
GO:0030210 |
heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.0 |
0.3 |
GO:0003214 |
cardiac left ventricle morphogenesis(GO:0003214) |
| 0.0 |
0.2 |
GO:0015747 |
urate transport(GO:0015747) |
| 0.0 |
0.2 |
GO:0014912 |
negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.0 |
0.2 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.0 |
1.3 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.0 |
0.2 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.0 |
0.1 |
GO:0016024 |
CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.0 |
0.6 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.0 |
0.3 |
GO:0043606 |
histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.0 |
2.7 |
GO:0000271 |
polysaccharide biosynthetic process(GO:0000271) |
| 0.0 |
0.7 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.0 |
0.6 |
GO:0009642 |
response to light intensity(GO:0009642) |
| 0.0 |
0.5 |
GO:0097296 |
activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
| 0.0 |
0.1 |
GO:1903348 |
positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.0 |
0.7 |
GO:0042762 |
regulation of sulfur metabolic process(GO:0042762) |
| 0.0 |
1.1 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
| 0.0 |
0.7 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.0 |
0.2 |
GO:0048749 |
compound eye development(GO:0048749) |
| 0.0 |
0.1 |
GO:0090394 |
negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.0 |
0.3 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.0 |
0.2 |
GO:0033523 |
histone H2B ubiquitination(GO:0033523) |
| 0.0 |
0.2 |
GO:2000312 |
regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.0 |
0.1 |
GO:0018312 |
peptidyl-serine ADP-ribosylation(GO:0018312) |
| 0.0 |
0.3 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.0 |
2.0 |
GO:0006493 |
protein O-linked glycosylation(GO:0006493) |
| 0.0 |
0.3 |
GO:0006537 |
glutamate biosynthetic process(GO:0006537) |
| 0.0 |
0.1 |
GO:0071474 |
cellular hyperosmotic response(GO:0071474) |
| 0.0 |
0.2 |
GO:0009233 |
menaquinone metabolic process(GO:0009233) |
| 0.0 |
0.4 |
GO:0031047 |
gene silencing by RNA(GO:0031047) |
| 0.0 |
2.1 |
GO:0010508 |
positive regulation of autophagy(GO:0010508) |
| 0.0 |
0.3 |
GO:0021894 |
cerebral cortex GABAergic interneuron development(GO:0021894) |
| 0.0 |
0.1 |
GO:0030104 |
water homeostasis(GO:0030104) |
| 0.0 |
2.0 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 |
0.2 |
GO:0051642 |
centrosome localization(GO:0051642) |
| 0.0 |
0.6 |
GO:1900364 |
negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.0 |
0.1 |
GO:0033563 |
dorsal/ventral axon guidance(GO:0033563) |
| 0.0 |
0.2 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.0 |
0.3 |
GO:0090169 |
regulation of spindle assembly(GO:0090169) |
| 0.0 |
0.3 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.0 |
0.3 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.0 |
0.5 |
GO:0060149 |
negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by miRNA(GO:0060965) negative regulation of gene silencing by RNA(GO:0060967) |
| 0.0 |
0.5 |
GO:0060973 |
cell migration involved in heart development(GO:0060973) |
| 0.0 |
0.9 |
GO:1904380 |
endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.0 |
0.3 |
GO:0034384 |
high-density lipoprotein particle clearance(GO:0034384) |
| 0.0 |
0.4 |
GO:0046174 |
polyol catabolic process(GO:0046174) |
| 0.0 |
0.1 |
GO:1990569 |
UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.0 |
0.3 |
GO:0032897 |
negative regulation of viral transcription(GO:0032897) |
| 0.0 |
0.1 |
GO:2000059 |
negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.0 |
0.5 |
GO:0035246 |
peptidyl-arginine N-methylation(GO:0035246) |
| 0.0 |
1.1 |
GO:0050913 |
sensory perception of bitter taste(GO:0050913) |
| 0.0 |
0.9 |
GO:0050855 |
regulation of B cell receptor signaling pathway(GO:0050855) |
| 0.0 |
0.1 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.0 |
0.3 |
GO:0032596 |
protein transport within lipid bilayer(GO:0032594) protein transport into membrane raft(GO:0032596) |
| 0.0 |
0.0 |
GO:0032460 |
negative regulation of protein oligomerization(GO:0032460) |
| 0.0 |
0.3 |
GO:0006949 |
syncytium formation(GO:0006949) |
| 0.0 |
0.1 |
GO:0098902 |
regulation of membrane depolarization during action potential(GO:0098902) |
| 0.0 |
0.1 |
GO:0072600 |
establishment of protein localization to Golgi(GO:0072600) |
| 0.0 |
0.2 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.0 |
0.1 |
GO:0045737 |
positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.0 |
0.1 |
GO:0007056 |
spindle assembly involved in female meiosis(GO:0007056) |
| 0.0 |
0.0 |
GO:0035587 |
purinergic receptor signaling pathway(GO:0035587) |
| 0.0 |
0.2 |
GO:1901503 |
ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.0 |
0.1 |
GO:0038110 |
interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.0 |
0.4 |
GO:0045948 |
positive regulation of translational initiation(GO:0045948) |
| 0.0 |
0.9 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.0 |
0.1 |
GO:0033058 |
directional locomotion(GO:0033058) |
| 0.0 |
0.1 |
GO:1900154 |
regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.0 |
0.7 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.0 |
0.3 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.0 |
0.1 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.0 |
0.1 |
GO:0044026 |
DNA hypermethylation(GO:0044026) |
| 0.0 |
0.1 |
GO:0016185 |
synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 0.0 |
3.0 |
GO:0042795 |
snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.0 |
0.1 |
GO:0044819 |
mitotic G1 DNA damage checkpoint(GO:0031571) mitotic G1/S transition checkpoint(GO:0044819) |
| 0.0 |
0.1 |
GO:0035878 |
nail development(GO:0035878) |
| 0.0 |
0.2 |
GO:0044210 |
'de novo' CTP biosynthetic process(GO:0044210) |
| 0.0 |
0.6 |
GO:0090110 |
cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.0 |
0.6 |
GO:2000392 |
regulation of lamellipodium morphogenesis(GO:2000392) |
| 0.0 |
0.4 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.0 |
0.2 |
GO:0051583 |
dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 0.0 |
0.9 |
GO:0070911 |
global genome nucleotide-excision repair(GO:0070911) |
| 0.0 |
0.8 |
GO:0006590 |
thyroid hormone generation(GO:0006590) |
| 0.0 |
0.4 |
GO:0033962 |
cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.0 |
0.4 |
GO:1990090 |
cellular response to nerve growth factor stimulus(GO:1990090) |
| 0.0 |
1.4 |
GO:0006368 |
transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.0 |
0.1 |
GO:0009624 |
response to nematode(GO:0009624) |
| 0.0 |
0.3 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.0 |
0.9 |
GO:0032986 |
protein-DNA complex disassembly(GO:0032986) |
| 0.0 |
0.1 |
GO:0045648 |
positive regulation of erythrocyte differentiation(GO:0045648) |
| 0.0 |
0.2 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.0 |
0.1 |
GO:0002052 |
positive regulation of neuroblast proliferation(GO:0002052) |
| 0.0 |
0.2 |
GO:0044126 |
regulation of growth of symbiont in host(GO:0044126) |
| 0.0 |
0.3 |
GO:0001514 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 |
0.2 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.0 |
0.2 |
GO:0052565 |
response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.0 |
0.5 |
GO:0019371 |
cyclooxygenase pathway(GO:0019371) |
| 0.0 |
4.5 |
GO:0043484 |
regulation of RNA splicing(GO:0043484) |
| 0.0 |
0.1 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.0 |
1.3 |
GO:0070423 |
nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) |
| 0.0 |
0.1 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.0 |
0.5 |
GO:0048017 |
phosphatidylinositol-mediated signaling(GO:0048015) inositol lipid-mediated signaling(GO:0048017) |
| 0.0 |
0.2 |
GO:0038111 |
interleukin-7-mediated signaling pathway(GO:0038111) response to interleukin-7(GO:0098760) cellular response to interleukin-7(GO:0098761) |
| 0.0 |
0.4 |
GO:0006662 |
glycerol ether metabolic process(GO:0006662) |
| 0.0 |
0.2 |
GO:0015908 |
fatty acid transport(GO:0015908) |
| 0.0 |
0.1 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.0 |
0.0 |
GO:0001878 |
response to yeast(GO:0001878) |
| 0.0 |
0.4 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.0 |
0.1 |
GO:0000066 |
mitochondrial ornithine transport(GO:0000066) |
| 0.0 |
0.2 |
GO:0021680 |
cerebellar Purkinje cell layer development(GO:0021680) |
| 0.0 |
0.2 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.0 |
0.1 |
GO:0014028 |
notochord formation(GO:0014028) |
| 0.0 |
0.2 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.0 |
0.3 |
GO:0021549 |
cerebellum development(GO:0021549) |
| 0.0 |
0.1 |
GO:0048341 |
paraxial mesoderm formation(GO:0048341) |
| 0.0 |
0.3 |
GO:0031647 |
regulation of protein stability(GO:0031647) |
| 0.0 |
0.1 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.0 |
0.3 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.0 |
0.0 |
GO:0032350 |
regulation of hormone metabolic process(GO:0032350) |
| 0.0 |
1.6 |
GO:0003341 |
cilium movement(GO:0003341) |
| 0.0 |
0.4 |
GO:0060394 |
negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.0 |
0.0 |
GO:0043506 |
regulation of JUN kinase activity(GO:0043506) |
| 0.0 |
0.1 |
GO:0019417 |
sulfur oxidation(GO:0019417) |
| 0.0 |
0.5 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.0 |
0.1 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.0 |
0.9 |
GO:0001844 |
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
| 0.0 |
0.3 |
GO:1990001 |
inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.0 |
0.4 |
GO:0003323 |
type B pancreatic cell development(GO:0003323) |
| 0.0 |
0.1 |
GO:0009822 |
alkaloid catabolic process(GO:0009822) |
| 0.0 |
1.1 |
GO:0061245 |
establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
| 0.0 |
0.4 |
GO:0006032 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.0 |
0.1 |
GO:0008291 |
acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
| 0.0 |
0.2 |
GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
| 0.0 |
0.3 |
GO:0046039 |
GTP metabolic process(GO:0046039) |
| 0.0 |
0.0 |
GO:0048690 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 0.0 |
0.1 |
GO:0042481 |
regulation of odontogenesis(GO:0042481) |
| 0.0 |
0.2 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.0 |
0.2 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.0 |
0.1 |
GO:0090156 |
negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.0 |
0.4 |
GO:1900077 |
negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
| 0.0 |
0.5 |
GO:0051568 |
histone H3-K4 methylation(GO:0051568) |
| 0.0 |
0.1 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.0 |
0.6 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.0 |
0.3 |
GO:2000347 |
negative regulation of myoblast fusion(GO:1901740) positive regulation of hepatocyte proliferation(GO:2000347) |
| 0.0 |
3.4 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 |
0.1 |
GO:1903288 |
positive regulation of potassium ion import(GO:1903288) |
| 0.0 |
0.6 |
GO:0042509 |
regulation of tyrosine phosphorylation of STAT protein(GO:0042509) |
| 0.0 |
0.2 |
GO:0034465 |
response to carbon monoxide(GO:0034465) |
| 0.0 |
0.2 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.0 |
0.1 |
GO:2000785 |
regulation of autophagosome assembly(GO:2000785) |
| 0.0 |
0.4 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.0 |
0.5 |
GO:0008210 |
estrogen metabolic process(GO:0008210) |
| 0.0 |
0.1 |
GO:0050432 |
catecholamine secretion(GO:0050432) |
| 0.0 |
0.1 |
GO:1900086 |
regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
| 0.0 |
0.1 |
GO:0002190 |
cap-independent translational initiation(GO:0002190) |
| 0.0 |
5.7 |
GO:0000375 |
RNA splicing, via transesterification reactions(GO:0000375) |
| 0.0 |
0.2 |
GO:0042749 |
regulation of circadian sleep/wake cycle(GO:0042749) |
| 0.0 |
0.1 |
GO:0010517 |
regulation of phospholipase activity(GO:0010517) |
| 0.0 |
0.2 |
GO:0071670 |
smooth muscle cell chemotaxis(GO:0071670) |
| 0.0 |
0.1 |
GO:0010818 |
T cell chemotaxis(GO:0010818) |
| 0.0 |
0.1 |
GO:1903069 |
regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
| 0.0 |
0.0 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.0 |
0.1 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.0 |
0.1 |
GO:0070672 |
response to interleukin-15(GO:0070672) |
| 0.0 |
0.1 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.0 |
0.4 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.0 |
0.2 |
GO:0045995 |
regulation of embryonic development(GO:0045995) |
| 0.0 |
0.1 |
GO:0051708 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.0 |
0.3 |
GO:0050684 |
regulation of mRNA processing(GO:0050684) |
| 0.0 |
0.2 |
GO:0000414 |
regulation of histone H3-K36 methylation(GO:0000414) |
| 0.0 |
0.2 |
GO:0045582 |
positive regulation of T cell differentiation(GO:0045582) |
| 0.0 |
0.1 |
GO:0001692 |
histamine metabolic process(GO:0001692) |
| 0.0 |
0.1 |
GO:0032740 |
positive regulation of interleukin-17 production(GO:0032740) |
| 0.0 |
0.1 |
GO:0072734 |
response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.0 |
0.2 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.0 |
0.1 |
GO:1900864 |
mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.0 |
0.8 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.0 |
0.1 |
GO:0046465 |
dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
| 0.0 |
0.1 |
GO:0051125 |
regulation of actin nucleation(GO:0051125) |
| 0.0 |
0.2 |
GO:0046500 |
S-adenosylmethionine metabolic process(GO:0046500) |
| 0.0 |
0.0 |
GO:0060856 |
establishment of blood-brain barrier(GO:0060856) |
| 0.0 |
0.2 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.0 |
0.0 |
GO:0072611 |
interleukin-13 secretion(GO:0072611) regulation of interleukin-13 secretion(GO:2000665) positive regulation of interleukin-13 secretion(GO:2000667) |
| 0.0 |
0.1 |
GO:0031998 |
regulation of fatty acid beta-oxidation(GO:0031998) |
| 0.0 |
0.1 |
GO:0034446 |
substrate adhesion-dependent cell spreading(GO:0034446) |
| 0.0 |
0.8 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.0 |
0.0 |
GO:0002176 |
male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
| 0.0 |
0.6 |
GO:0050871 |
positive regulation of B cell activation(GO:0050871) |
| 0.0 |
0.0 |
GO:0070445 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.0 |
0.1 |
GO:0050919 |
negative chemotaxis(GO:0050919) |
| 0.0 |
0.1 |
GO:0038166 |
angiotensin-activated signaling pathway(GO:0038166) |
| 0.0 |
0.1 |
GO:1902035 |
positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.0 |
2.4 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.0 |
0.1 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.0 |
0.2 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.0 |
0.1 |
GO:0090083 |
regulation of inclusion body assembly(GO:0090083) |
| 0.0 |
0.1 |
GO:0098903 |
regulation of membrane repolarization during action potential(GO:0098903) |
| 0.0 |
0.2 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.0 |
1.3 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 0.0 |
0.1 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.0 |
0.0 |
GO:0071674 |
positive regulation of macrophage chemotaxis(GO:0010759) mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
| 0.0 |
0.0 |
GO:2001034 |
positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 0.0 |
0.2 |
GO:0045008 |
depyrimidination(GO:0045008) |
| 0.0 |
0.0 |
GO:0002024 |
diet induced thermogenesis(GO:0002024) |
| 0.0 |
0.7 |
GO:0048208 |
vesicle coating(GO:0006901) vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
| 0.0 |
0.4 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
| 0.0 |
0.1 |
GO:0060573 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.0 |
0.1 |
GO:0048535 |
lymph node development(GO:0048535) |
| 0.0 |
0.1 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.0 |
0.0 |
GO:0070898 |
RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.0 |
0.1 |
GO:0009258 |
10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 0.0 |
0.0 |
GO:0090287 |
regulation of cellular response to growth factor stimulus(GO:0090287) |
| 0.0 |
0.7 |
GO:0043647 |
inositol phosphate metabolic process(GO:0043647) |
| 0.0 |
0.9 |
GO:1903749 |
positive regulation of establishment of protein localization to mitochondrion(GO:1903749) |
| 0.0 |
0.1 |
GO:0046373 |
arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
| 0.0 |
0.0 |
GO:0070175 |
positive regulation of enamel mineralization(GO:0070175) |
| 0.0 |
0.2 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.0 |
0.0 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 0.0 |
0.2 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |